Autism breakthrough: Trial drug given 'accelerated status' paves way for faster approval



A POTENTIALLY “game changing” drug that tackles the root causes of autism could be available in the UK within five years, experts say. Initial trial results for Balovaptan has so impressed US regulators, it has been given “accelerated status”, paving the way for faster approval.



Read More